Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma
- PMID: 24984957
- DOI: 10.1177/1066896914540998
Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma
Abstract
Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are 2 skin neoplasms with distinct potentials to invasion and metastasis. Actinic keratosis (AK) is a precursor lesion of SCC. Immunohistochemistry was performed to evaluate the expression of MMP-2 and MT1-MMP in samples of BCC (n = 29), SCC (n = 12), and AK (n = 13). The ratio of positive cells to total cells was used to quantify the staining. Statistical significance was considered under the level P < .05. We found a higher expression of MMP-2 in tumor stroma and parenchyma of SCC as compared to BCC. The expression of this protein was also similar between SCC and its precursor actinic keratosis, and it was higher in the stroma of high-risk BCC when compared to low-risk BCC. MT1-MMP, which is an activator of MMP-2, was similarly expressed in all groups. Our results suggest that MMP-2 expression may contribute to the distinct invasive patterns seen in SCC and BCC.
Keywords: actinic keratosis; basal cell carcinoma; matrix metalloproteinase-2; membrane-type matrix metalloproteinase-1; squamous cell carcinoma.
© The Author(s) 2014.
Similar articles
-
Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.Pathol Res Pract. 2013 Nov;209(11):705-9. doi: 10.1016/j.prp.2013.08.002. Epub 2013 Aug 16. Pathol Res Pract. 2013. PMID: 24011615
-
An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.Coll Antropol. 2008 Oct;32 Suppl 2:61-5. Coll Antropol. 2008. PMID: 19138009
-
Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.Anticancer Res. 2016 Apr;36(4):1591-7. Anticancer Res. 2016. PMID: 27069135
-
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.Cutis. 2011 Apr;87(4):201-7. Cutis. 2011. PMID: 21644496 Review.
-
[The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].Rev Med Chir Soc Med Nat Iasi. 2003 Jul-Sep;107(3):494-501. Rev Med Chir Soc Med Nat Iasi. 2003. PMID: 14756051 Review. Romanian.
Cited by
-
A Panel of Potential Serum Markers Related to Angiogenesis, Antioxidant Defense and Hypoxia for Differentiating Cutaneous Squamous Cell Carcinomas from Actinic Keratoses.J Pers Med. 2024 Jan 17;14(1):103. doi: 10.3390/jpm14010103. J Pers Med. 2024. PMID: 38248804 Free PMC article.
-
Extracellular matrix in skin diseases: The road to new therapies.J Adv Res. 2023 Sep;51:149-160. doi: 10.1016/j.jare.2022.11.008. Epub 2022 Dec 5. J Adv Res. 2023. PMID: 36481476 Free PMC article. Review.
-
Topical Treatment of Actinic Keratosis and Metalloproteinase Expression: A Clinico-Pathological Retrospective Study.Int J Mol Sci. 2022 Sep 26;23(19):11351. doi: 10.3390/ijms231911351. Int J Mol Sci. 2022. PMID: 36232651 Free PMC article.
-
Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.Front Med (Lausanne). 2022 Apr 29;9:879500. doi: 10.3389/fmed.2022.879500. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572966 Free PMC article. Review.
-
Matrix metalloproteinases in keratinocyte carcinomas.Exp Dermatol. 2021 Jan;30(1):50-61. doi: 10.1111/exd.14183. Epub 2020 Sep 17. Exp Dermatol. 2021. PMID: 32869366 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
